Innofix-50mg/5ml Oral Suspension

Innofix suspension is a third-generation cephalosporin for pediatric bacterial infections. The strawberry-flavored suspension supports adherence and is appropriate where cefixime susceptibility is documented in Tanzanian settings.

Available Product Formulations

Dry powder for oral suspension: when reconstituted provides 50 mg/5 ml cefixime (total volume per bottle varies by brand).

Uses

Acute otitis media, pharyngitis/tonsillitis, uncomplicated UTIs, and certain mild-to-moderate respiratory infections due to susceptible organisms.

How to Use

• Dosage: Children: typically 8 mg/kg/day once daily or divided q12h (max per prescriber).
• Duration: Usually 5–10 days; complete full course.

Side Effects

Diarrhea, abdominal pain, nausea, rash. Rarely, hypersensitivity reactions.

Interactions

May affect results of urine glucose tests. Probenecid can increase levels. Use caution with anticoagulants (may enhance effect).

Warnings

Screen for cephalosporin/penicillin allergy. Reconstitute with safe, clean water and refrigerate if labeling instructs; discard after the labeled period (often 7–14 days). Use according to local resistance guidance.

Summary of Important Information

Active Ingredients	Cefixime 50 mg/5 ml (after reconstitution)
Dosage Frequency	Once daily or every 12 hours
Starting Time	Start after clinician’s prescription
Duration of Use	5–10 days
Common Side Effects	Diarrhea, abdominal pain, rash
Warnings	Allergy caution; storage and discard rules post-reconstitution

How Innofix 50mg/5ml Oral Suspension Works

Cefixime inhibits bacterial cell wall synthesis by binding penicillin-binding proteins, leading to cell lysis (bactericidal).